In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!

In this episode of M&A Talks Europe, we dive into one of the largest M&A deals of the year—the acquisition of Covestro, a leading German chemical corporation, by Abu Dhabi National Oil Company (ADNOC). We explore the strategic rationale behind the takeover, its implications for both Covestro and ADNOC, and what this deal reveals about the energy transition strategies of Gulf countries. Let's discuss the numbers, the challenges of the chemical industry, and how Middle Eastern investors are positioning themselves in European markets.

In this episode of M&A Talks Europe, we dive into LVMH’s acquisition of a minority stake in Italian fashion giant Moncler. Explore Moncler's unique history, its visionary CEO Remo Ruffini, and how this deal could shape the future of luxury fashion. We’ll also discuss Moncler’s innovative approach to fashion shows, the company’s shareholder structure, their recent acquisition of Stone Island, and how LVMH’s involvement could influence future market consolidation. Tune in for key insights into the business side of luxury fashion.